| Dr Cecelia Tai-lin Yu, MD | |
|
373 New Boston Rd, Fall River, MA 02720-5814 | |
| (508) 679-0911 | |
| (508) 536-0310 |
| Full Name | Dr Cecelia Tai-lin Yu |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 373 New Boston Rd, Fall River, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558467415 | NPI | - | NPPES |
| 07-00947 | Other | MA | UNITED HEALTH CARE |
| 3183777 | Medicaid | MA | |
| 156624 | Other | MA | TUFTS |
| B20787202 | Other | MA | CIGNA |
| 130983 | Other | MA | HARVARD PILGRIM |
| J19207 | Other | MA | BLUECROSS AND BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 156624 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gyn-ob Associates Inc | 8123073665 | 7 |
News Archive
Researchers at McGill University in Montreal on Tuesday announced they will soon launch an international clinical trial to determine if latent tuberculosis can be treated successfully with a four-month treatment course of the TB drug rifampin rather than the standard nine-month treatment with the TB drug isoniazid, the CP/Toronto Sun reports.
Leaders from the African, Caribbean and Pacific (ACP) group of nations and the European Union launched "wide-ranging talks" in Kinshasa, Democratic Republic of Congo, on Thursday, Agence France-Presse reports. Approximately 450 lawmakers from 110 countries attended the opening.
Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
› Verified 6 days ago
| Entity Name | Gyn-ob Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215009196 PECOS PAC ID: 8123073665 Enrollment ID: O20050317000071 |
News Archive
Researchers at McGill University in Montreal on Tuesday announced they will soon launch an international clinical trial to determine if latent tuberculosis can be treated successfully with a four-month treatment course of the TB drug rifampin rather than the standard nine-month treatment with the TB drug isoniazid, the CP/Toronto Sun reports.
Leaders from the African, Caribbean and Pacific (ACP) group of nations and the European Union launched "wide-ranging talks" in Kinshasa, Democratic Republic of Congo, on Thursday, Agence France-Presse reports. Approximately 450 lawmakers from 110 countries attended the opening.
Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
› Verified 6 days ago
| Entity Name | Citizens For Citizens Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528252954 PECOS PAC ID: 9739403999 Enrollment ID: O20150116000041 |
News Archive
Researchers at McGill University in Montreal on Tuesday announced they will soon launch an international clinical trial to determine if latent tuberculosis can be treated successfully with a four-month treatment course of the TB drug rifampin rather than the standard nine-month treatment with the TB drug isoniazid, the CP/Toronto Sun reports.
Leaders from the African, Caribbean and Pacific (ACP) group of nations and the European Union launched "wide-ranging talks" in Kinshasa, Democratic Republic of Congo, on Thursday, Agence France-Presse reports. Approximately 450 lawmakers from 110 countries attended the opening.
Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cecelia Tai-lin Yu, MD 373 New Boston Rd, Fall River, MA 02720-5814 Ph: (508) 679-0911 | Dr Cecelia Tai-lin Yu, MD 373 New Boston Rd, Fall River, MA 02720-5814 Ph: (508) 679-0911 |
News Archive
Researchers at McGill University in Montreal on Tuesday announced they will soon launch an international clinical trial to determine if latent tuberculosis can be treated successfully with a four-month treatment course of the TB drug rifampin rather than the standard nine-month treatment with the TB drug isoniazid, the CP/Toronto Sun reports.
Leaders from the African, Caribbean and Pacific (ACP) group of nations and the European Union launched "wide-ranging talks" in Kinshasa, Democratic Republic of Congo, on Thursday, Agence France-Presse reports. Approximately 450 lawmakers from 110 countries attended the opening.
Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
› Verified 6 days ago
Margaret Tang Lee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Fall River, MA 02720 Phone: 508-676-3411 | |
Dr. Susanne Marie Matias-gomes, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 2002, Fall River, MA 02720 Phone: 508-676-3411 Fax: 508-235-6265 | |
Dr. Mohamed F Ali, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 373 New Boston Rd, Fall River, MA 02720 Phone: 508-679-0911 Fax: 508-736-0310 | |
Alan Robert Mcnamara, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 373 New Boston Rd, Fall River, MA 02720 Phone: 508-679-0911 | |
Dr. Michelle L Hughes, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Hanover St, Ste 3a, Fall River, MA 02720 Phone: 508-679-7770 Fax: 508-679-7786 | |
Dr. Ericka Michelle Hersh, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Hanover St, Suite 1e, Fall River, MA 02720 Phone: 508-679-7770 | |
Caroline A. Beliveau, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 484 Highland Ave, Fall River, MA 02720 Phone: 508-679-2555 Fax: 508-672-5442 |